ACRVVSAKAN• 3 Months (Normalized)
ACRV vs AKAN (Acrivon Therapeutics Inc. vs Akanda Corp.)
Showing Closing Date Range from Jun, 19 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.72
+8.86%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
AKAN Performance $3.17
-79%
Akanda Corp.
Normalized Baseline0.00%
Alpha Spread Margin ACRV LEADS
+87.86%
ACRV outperforming by 87.86%
ACRVAKAN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV AKAN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ACRV Price | ACRV Gain (%) | AKAN Price | AKAN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $1.72 | +8.86% | $3.17 | -79.00% | +87.86% |
| Sep 16, 2026 | $1.70 | +7.59% | $2.72 | -81.95% | +89.54% |
| Sep 15, 2026 | $1.83 | +15.82% | $2.66 | -82.35% | +98.17% |
| Sep 14, 2026 | $1.96 | +24.05% | $2.79 | -81.49% | +105.54% |
| Sep 11, 2026 | $2.00 | +26.58% | $3.07 | -79.63% | +106.21% |
| Sep 10, 2026 | $2.04 | +29.11% | $3.00 | -80.09% | +109.20% |
| Sep 09, 2026 | $1.99 | +25.95% | $3.25 | -78.43% | +104.38% |
| Sep 08, 2026 | $2.10 | +32.91% | $3.28 | -78.23% | +111.14% |
| Sep 04, 2026 | $2.13 | +34.81% | $3.35 | -77.77% | +112.58% |
| Sep 03, 2026 | $2.06 | +30.38% | $3.67 | -75.65% | +106.03% |
| Sep 02, 2026 | $2.15 | +36.08% | $3.74 | -75.18% | +111.26% |
| Sep 01, 2026 | $2.07 | +31.01% | $3.70 | -75.45% | +106.46% |
| Aug 31, 2026 | $2.09 | +32.28% | $4.08 | -72.96% | +105.24% |
| Aug 28, 2026 | $2.06 | +30.38% | $3.89 | -74.19% | +104.57% |
| Aug 27, 2026 | $2.15 | +36.08% | $4.23 | -71.93% | +108.01% |
Page 1 of 5